The Conversation (0)
Brace Pharmaceuticals, an investment company created by EMS S/A, Brazil’s largest pharmaceutical company, has opened a US headquarters in Maryland and plans to invest $200 million into the new operation, reported MDBizNews.
Brace Pharmaceuticals, an investment company created by EMS S/A, Brazil’s largest pharmaceutical company, has opened a US headquarters in Maryland and plans to invest $200 million into the new operation, reported MDBizNews.
As quoted in the market news:
The company, which is located in the Rockville Innovation Center, develops and commercializes products in the late stage of clinical development and helps research and development companies successfully finish their developments and obtain FDA market approval. Brace recently entered into its first venture investment in a U.S. company with Gliknik, a Baltimore-based biopharmaceutical company that is creating new therapies for cancer and immune disorders.Â
Read the full article on MDBizNews